The effect of propolis and its components on eicosanoid production during the inflammatory response

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 6, 1996, Pages 441-449

  Mirzoeva, O K ^a   Calder, P C ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEIC ACID; CAFFEIC ACID DERIVATIVE; CALCIMYCIN; ICOSANOID; INDOMETACIN; LEUKOTRIENE B4; LEUKOTRIENE C4; LIPOPOLYSACCHARIDE; LIPOXYGENASE INHIBITOR; NARINGENIN; NORDIHYDROGUAIARETIC ACID; PROPOLIS; PROSTAGLANDIN E2; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALIA; MURINAE; PROPOLIS;

EID: 0030457644     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90129-5     Document Type: Article

References (44)

1. Serhan C. N. Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim Biophys Acta 1994; 1212: 1-25.
2. Samuelsson B., Dahlen S. E., Lindgren J. A., Rouzer C. A., Serhan C. N. Leukotrienes and lipoxins: structures, biosynthesis and biological effects. Science 1987; 237: 1171-1176.
3. Samuelsson B. An elucidation of the arachidonic acid cascade discovery of prostaglandins, thromboxane and leukotrienes. Drugs 1987; 33: 2-9.
4. Kinsella J. E., Lokesh B., Broughton S., Whelan J. Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 1990; 6: 24-44.
5. Hwang D. Essential fatty acids and immune response. FASEB J 1989; 3: 2052-2061.
6. Samuelsson B. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568-575.
7. Salmon J. A., Higgs G. A. Prostaglandins and leukotrienes as inflammatory mediators. Br Med Bull 1987; 43: 285-296.
8. Ninnemann J. L. Prostaglandins, leukotrienes and the immune response. Cambridge University Press, 1988: 3.
9. Marx J. L. The leukotrienes in allergy and inflammation. Science 1982; 215: 1380-1383.
10. Vane J. The evolution of non-steroidal anti-inflammatory drugs and their mechanism of action. Drugs 1987; 33: 18-27.
11. Ford-Hutchinson A. W. Leukotrienes: their formation and role as inflammatory mediators. Fed Proc 1985; 44: 25-29.
12. Kalkbrenner F., Wurm G., von Bruchhausen F. In vitro inhibition and stimulation of purified prostaglandin endoperoxide synthase by flavonoids: structure-activity relationship. Pharmacology 1992; 44: 1-12.
13. Cucurou C., Battioni J. P., Thang D. C., Nam N. H., Mansuy D. Mechanism of inactivation of lipoxygenases by phenidone and BW755C. Biochemistry 1991; 30: 8964-8970.
14. Cryer B., Feldman M. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage. Arch Intern Med 1992; 152: 1145-1155.
15. Higgs G. A., Flower R. J., Vane J. R. A new approach to anti-inflammatory drugs. Biochem Pharmacol 1979; 28: 1959-1961.
16. Wheeler E. L., Berry D. L. In vitro inhibition of mouse epidermal cell lipoxygenase by flavonoids: structure-activity relationships. Carcinogenesis 1986; 7: 33-36.
17. Grunberger D., Banerjee R., Eisinger K. et al. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 1988; 44: 230-232.
18. Khayyal M. T., ElGhazaly M. A., ElKhatib A. S. Mechanisms involved in the anti-inflammatory effect of propolis extract. Drug Exp Clin Res 1993; 19: 197-203.
19. Dobrovolski J. W., Vohora S. B., Sharma K., Shah S. A., Nagvi S. A. H., Dandiya P. C. Antibacterial, antifungal, antiamoebic, anti-inflammatory and antipyretic studies on propolis bee products. J Ethnopharmacol 1991; 35: 77-82.
20. Grange J. M., Davey R. W. Antibacterial properties of propolis (bee glue). J Roy Soc Med 1990; 83: 159-160.
21. Hausen B. M., Wollenweber E., Senff H., Post B. Propolis allergy (I). Origin, properties, usage and literature review. Contact Dermatitis 1987; 17: 163-170.
22. Hausen B. M., Wollenweber E. Propolis allergy. (III). Sensitization studies with minor constituents. Contact Dermatitis 1988; 19: 296-303.
23. Ghisalberti E. L. Propolis: a review. Bee World 1979; 60: 59-84.
24. Vennat B., ArvouetGrand A., Gross D., Pourrat A. Qualitative and quantitative analysis of flavonoids and identification of phenolic acids from a propolis extract. J Pharm Belg 1995; 50: 438-444.
25. Middleton E., Kandswami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem Pharmacol 1992; 43: 1167-1179.
26. Rapta P., Misik V., Stasko A., Vrabel I. Redox intermediates of flavonoids and caffeic acid esters from propolis: an EPR spectroscopy and cyclic voltammetry study. Free Rad Biol Med 1995; 18: 901-908.
27. Das A., Wang J. H., Lien E. J. Carcinogenicity, mutagenicity and cancer preventing activities of flavanoids: A structure-system-activity relationship (SSAR) analysis. Prog Drug Res 1994; 42: 133-166.
28. Ghisalberti E. L., Jefferies P., Lanteri R. Potential drugs from propolis. In: Frigerio A., Ghisalberti E. L., eds Mass Spectrometry in Drug Metabolism. Plenum Press: New York, 1977: 111.
29. Greenaway W., Scaysbrook T., Whatley F. R. The analysis of bud exudate of Populus x euramericana, and of propolis, by gas chromatography-mass spectrometry. Proc Roy Soc Lon 1987; B232: 249-272.
30. Ivanovska N. D., Dimov V. B., Pavlova S., Bankova V. S., Popov S. S. Immunomodulatory action of propolis. V. Anticomplementary activity of a water-soluble derivative. J Ethnopharmacol 1995; 47: 135-143.
31. Rao C. V., Desai D., Simi B., Kulkarni N., Amin S., Reddy B. S. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res 1993; 53: 4182-4188.
32. Chiao C., Carothers A. M., Grunberger D., Solomon G., Preston G. A., Barret J. C. Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells. Cancer Res 1995; 55: 3576-3583.
33. Sud'ina G. F., Mirzoeva O. K., Pushkareva M. A., Korshunova G. A., Sumbatyan N. V., Varfolomeev S. D. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993; 329: 21-24.
34. Mirzoeva O. K., Sud'ina G. F., Pushkareva M. A., Korshunova G. A., Sumbatyan N. V., Varfolomeev S. D. Lipophilic derivatives of caffeic acid as lipoxygenase inhibitors with antioxidant properties. Bioorg Khim 1995; 21: 143-151.
35. Yaqoob P., Calder P. Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol 1995; 163: 120-128.
36. 4 and suppresses levels of resident and elicited leukocytes in acute inflammation. J Immunol 1988; 140: 228-233.
37. Pradelles P., Grassi J., Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholinesterase. Method Enzymol 1990; 187: 82-89.
38. Takemura R., Werb Z. Secretory products of macrophages and their physiological functions. Am J Physiol 1984; 246: C1-C9.
39. Anderson D. C. The role of phagocytic cells in host defense and inflammatory disease. Nutrition 1990; 6: 5-15.
40. 4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. J Clin Ivest 1987; 80: 1114-1124.
41. Landolfi R., Mower R. L., Steiner M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem Pharmacol 1984; 33: 1525-1530.
42. Fitzpatrick F. A., Wynalda M. A. In vivo suppression of prostaglandins biosynthesis by nonsteroidal antiinflammatory agents. Prostaglandins 1976; 12: 1037-1051.
43. Naden R. P., Iliya C. A., Arant B. S., Gant N. F., Rosenfeld C. R. Hemodynamic effects of indomethacin in chronically instrumented pregnant sheep. Am J Obstet Gynecol 1985; 151: 484-494.
44. Ivanovska N. D., Dimov V. B., Bankova V. S., Popov S. S. Immunomodulatory action of propolis. VI. Infuence of a water soluble derivative on complement activity in vivo. J Ethnopharmacol 1995; 47: 145-147.